3 Results for "

AS703569

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "AS703569" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-13072
CAS No.: 871357-89-0
Purity:  99.86%
Synonyms: AS-703569; R-763
Research Areas:  

Cancer

Cenisertib (AS-703569) is an ATP-competitive multi-kinase inhibitor that blocks the activity of Aurora-kinase-A/B, ABL1, AKT, STAT5 and FLT3. Cenisertib induces major growth-inhibitory effects by blocking the activity of several different molecular targets in neoplastic mast cells (MC). Cenisertib inhibits tumor growth in xenograft models of pancreatic, breast, colon, ovarian, and lung tumors and leukemia .
loading...
    loading...
Cat. No.: HY-13072R
CAS No.: 871357-89-0
Synonyms: AS-703569 (Standard); R-763 (Standard)
Research Areas:  

Cancer

Cenisertib (Standard) is the analytical standard of Cenisertib. This product is intended for research and analytical applications. Cenisertib (AS-703569) is an ATP-competitive multi-kinase inhibitor that blocks the activity of Aurora-kinase-A/B, ABL1, AKT, STAT5 and FLT3. Cenisertib induces major growth-inhibitory effects by blocking the activity of several different molecular targets in neoplastic mast cells (MC). Cenisertib inhibits tumor growth in xenograft models of pancreatic, breast, colon, ovarian, and lung tumors and leukemia .
loading...
    loading...
Cat. No.: HY-13072B
CAS No.: 1145859-64-8
Synonyms: AS-703569 benzoate; R-763 benzoate
Research Areas:  

Cancer

Cenisertib (AS-703569) benzoate is an ATP-competitive multi-kinase inhibitor that blocks the activity of Aurora-kinase-A/B, ABL1, AKT, STAT5 and FLT3. Cenisertib benzoate induces major growth-inhibitory effects by blocking the activity of several different molecular targets in neoplastic mast cells (MC). Cenisertib benzoate inhibits tumor growth in xenograft models of pancreatic, breast, colon, ovarian, and lung tumors and leukemia .
loading...
    loading...